Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult...
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States.
A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of...
The decision covers its use in cardiac magnetic resonance imaging to determine patient levels of myocardial perfusion and late gadolinium...
The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties.
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in adults with Type 1 diabetes who...
British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial.
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV.
Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches